Alimera Sciences Inc. (ALIM)
NASDAQ: ALIM
· Real-Time Price · USD
5.54
-0.01 (-0.18%)
At close: Sep 13, 2024, 10:00 PM
Alimera Sciences Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 99.68M | 90.22M | 80.75M | 68.48M | 58.71M | 55.78M | 54.13M | 54.06M | 52.61M | 59.71M | 59.03M | 58.84M | 59.16M | 47.5M |
Cost of Revenue | 13.57M | 12.16M | 10.84M | 9.34M | 8.58M | 8.32M | 7.98M | 7.82M | 7.5M | 7.15M | 7.03M | 7.06M | 6.9M | 6.58M |
Gross Profit | 79.87M | 71.81M | 66.76M | 55.98M | 50.13M | 47.45M | 46.15M | 46.24M | 45.11M | 52.56M | 52M | 51.79M | 52.26M | 40.92M |
Operating Income | 199K | -932K | -1.93M | -4.76M | -10.03M | -10.79M | -11.64M | -12.28M | -10.89M | -1.92M | -201K | 2.72M | 5.15M | -3.15M |
Interest Income | n/a | 1.69M | 3.36M | 3.36M | 4.86M | 4.55M | 4.25M | 4.25M | 2.75M | 1.36M | n/a | n/a | n/a | n/a |
Pretax Income | -14.71M | -21.36M | -20.05M | -20.05M | -24M | -17.09M | -18.08M | -18.44M | -17.54M | -6.24M | -3.93M | -895K | 2.85M | -7.9M |
Net Income | -14.7M | -21.41M | -20.13M | -20.13M | -24.03M | -17.12M | -18.11M | -18.43M | -17.36M | -6.68M | -4.37M | -1.24M | 2.32M | -7.79M |
Selling & General & Admin | 56.08M | 51.02M | 46.48M | 41.43M | 39.74M | 38.74M | 38.86M | 40.13M | 38.83M | 37.7M | 35.84M | 33.92M | 32.74M | 31.41M |
Research & Development | 17.44M | 16.82M | 16.63M | 16.09M | 16.52M | 16.81M | 16.23M | 15.72M | 14.51M | 14.15M | 13.78M | 12.56M | 11.76M | 10M |
Other Expenses | 2.4M | 2.4M | n/a | 1.77M | 2.03M | 2.7M | 2.71M | 2.68M | 2.67M | 2.63M | 2.58M | 2.58M | 2.61M | 2.66M |
Operating Expenses | 76.55M | 72.73M | 65.59M | 61.15M | 60.16M | 58.25M | 57.79M | 58.52M | 56.01M | 54.48M | 52.2M | 49.06M | 47.11M | 44.07M |
Interest Expense | 13.72M | 12.26M | 10.19M | 7.07M | 6.5M | 6.18M | 5.88M | 5.61M | 5.47M | 5.43M | 5.41M | 5.5M | 5.43M | 5.43M |
Selling & Marketing Expenses | 33.3M | 31.22M | 27.95M | 25.94M | 24.51M | 24.94M | 25.99M | 27.39M | 26.64M | 25.1M | 23.07M | 20.89M | 19.9M | 18.95M |
Cost & Expenses | 96.07M | 87.76M | 79.47M | 70.48M | 68.74M | 66.57M | 65.77M | 66.34M | 63.51M | 61.63M | 59.23M | 56.12M | 54.01M | 50.65M |
Income Tax Expense | -15K | 53K | 85K | 77K | 36K | 28K | 28K | -4K | -185K | 438K | 438K | 348K | 524K | -111K |
Shares Outstanding (Basic) | 54.38M | 54.36M | 54.42M | 32.11M | 8.09M | 7.03M | 7M | 7M | 7M | 6.99M | 6.92M | 6.92M | 7.35M | 5.75M |
Shares Outstanding (Diluted) | 54.38M | 54.36M | 54.42M | 32.11M | 8.09M | 7.03M | 7M | 7M | 7M | 6.99M | 6.93M | 6.92M | 7.36M | 5.75M |
EPS (Basic) | -0.28 | -1.46 | -2.53 | -3 | -3.71 | -2.92 | -2.59 | -2.64 | -2.49 | -1.01 | -0.79 | -0.38 | 0.10 | -1.44 |
EPS (Diluted) | -0.28 | -1.46 | -2.53 | -3 | -3.71 | -2.92 | -2.59 | -2.64 | -2.49 | -1.01 | -0.79 | -0.38 | 0.10 | -1.44 |
EBITDA | 11.38M | 9.15M | 5.99M | 503K | -6.17M | -8.13M | -8.97M | -9.6M | -8.23M | 712K | 2.38M | 5.3M | 7.76M | -489K |
EBIT | -996K | -9.11M | -9.86M | -12.99M | -17.5M | -10.91M | -12.2M | -12.83M | -12.07M | -807K | 1.48M | 4.61M | 8.27M | -2.47M |
Depreciation & Amortization | 12.38M | 11.15M | 8.75M | 6.39M | 3.89M | 2.7M | 2.71M | 2.68M | 2.67M | 2.63M | 2.58M | 2.58M | 2.61M | 2.66M |